Evidence map›Paper›PMID 38785724›Full record

ArticleBiosensors2024

Blood Coagulation-Inspired Fibrin Hydrogel for Portable Detection of Thrombin Based on Personal Glucometer.

Dan-Ni Yang, Shu-Yi Wu, Han-Yu Deng, Hao Zhang, Shan Shi, Shan Geng

Abstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dan-Ni YangChongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.
Shu-Yi WuBasic Medical College, Chongqing College of Traditional Chinese Medicine, Chongqing 402360, China.ORCID 0009-0001-1499-9076
Han-Yu DengChongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.
Hao ZhangChongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing 401331, China.ORCID 0000-0002-2229-9125
Shan ShiThe Central Laboratory, The Affiliated Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.
Shan GengThe Central Laboratory, The Affiliated Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.

Funding

Chongqing Medical and Pharmaceutical College, China ygz2023117Chongqing Medical and Pharmaceutical College, China ygzrc2023102Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau), China 2023MSXM006Chongqing Medical Scientific Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau), China 2024QNXM015Chongqing Postdoctoral Science Foundation, China CSTB2022NSCQ-BHX0687Chongqing Shapingba Medical Scientific Research Project (Joint project of Chongqing Shapingba Health Commission and Science and Technology Bureau), China 2023SQKWLH037Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission cstc2021jcyj-msxmX0353Science and Technology Research Program of Chongqing Municipal Education Commission, China KJQN202215131
6 · The paper itself

Abstract

As one of the biomarkers of coagulation system-related diseases, the detection of thrombin is of practical importance. Thus, this study developed a portable biosensor based on a personal glucometer for rapid detection of thrombin activity. Fibrinogen was used for the detection of thrombin, and the assay principle was inspired by the blood coagulation process, where thrombin hydrolyzes fibrinogen to produce a fibrin hydrogel, and the amount of invertase encapsulated in the fibrin hydrogel fluctuates in accordance with the activity of thrombin in the sample solution. The quantitative assay is conducted by measuring the amount of unencapsulated invertase available to hydrolyze the substrate sucrose, and the signal readout is recorded using a personal glucometer. A linear detection range of 0-0.8 U/mL of thrombin with a limit of detection of 0.04 U/mL was obtained based on the personal glucometer sensing platform. The results of the selectivity and interference experiments showed that the developed personal glucometer sensing platform is highly selective and accurate for thrombin activity. Finally, the reliability of the portable glucometer method for rapid thrombin detection in serum samples was investigated by measuring the recovery rate, which ranged from 92.8% to 107.7%. In summary, the fibrin hydrogel sensing platform proposed in this study offers a portable and versatile means for detecting thrombin using a personal glucometer. This approach not only simplifies the detection process, but also eliminates the need for large instruments and skilled operators, and substantially reduces detection costs.

Indexed as

Biosensing TechniquesBlood CoagulationFibrinHydrogelsThrombinBlood Glucose Self-MonitoringHumansFibrinHydrogelsThrombinbiosensorblood coagulationfibrin hydrogelpersonal glucometerthrombin activity

Identifiers

PMID38785724
PMCPMC11118845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.